STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
GKOS GLAUKOS CORPORATION StockScouter® Report
4
StockScouter® Score
GLAUKOS CORPORATION, a mid cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive
- The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
Concerns
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- Two or more executives, directors or major shareholders sold a small number of shares recently. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be in favor, growth stocks will be in favor, and healthcare stocks will be in favor.
Expected Risk/Return
Core Model Grades
A
D
F
D